
Day six, the vial has lived in the fridge for a week, and the mirror shows the same skin as last Monday apart from a few freckles that look darker than you remember. Here is the answer: melanotan 2 produces measurable darkening after about 5 doses, a tan other people notice in 2 to 3 weeks with modest UV exposure, and a peak 1 to 3 weeks after the last loading dose. The drug clears from blood in hours; the pigment lags it by weeks.
| Timeline question | Short answer |
|---|---|
| First visible change | Days 3 to 7: freckles, moles and old scars darken first |
| Tan others notice | Week 2 to 3 with 2 to 3 short UV sessions per week |
| Peak tan | Weeks 4 to 6, or 1 to 3 weeks after the last loading dose |
| MT2 half-life | No human value published; the closest tested analog clears from plasma in 0.8 to 1.7 hours |
| How long the tan lasts after stopping | Still measurable 3 weeks later; fades over 1 to 3 months without maintenance |
| Nothing by week 3 | Stop escalating and check the product |
Every number above comes from small University of Arizona trials of melanotan 2 and its linear sibling melanotan 1, plus user reports. No large trial of MT2 has ever been run, melanotan 2 is not FDA-approved for any use, and it is sold as a research compound. The dose and loading schedule live in the melanotan 2 dosage protocol, the unit math in the melanotan 2 dosage calculator, and melanotan 1's own numbers in the melanotan 1 dosage guide. This page covers one thing: how long MT2 takes, how long it lasts, and when waiting has stopped making sense.
Get your custom peptide protocol:
- Tailored to your body and goals
- Precise dosing and cycle length
- Safe stacking combinations
- Backed by peer-reviewed studies
- Ready in under 2 minutes
Why MT2 Acts in Hours but Tans in Weeks
Think of a darkroom print. The developer bath acts on the paper within seconds, but the image surfaces slowly, and it keeps darkening after you lift the sheet out of the tray. MT2 is the developer. Melanin is the image.
Literally stated: melanotan 2 is a cyclic seven-amino-acid analog of alpha-MSH that activates melanocortin receptors, including MC1R on melanocytes, and switches on melanin synthesis. In the first human pilot study, 5 subcutaneous doses given on alternating days produced measurable pigmentation of the face, upper body and buttock in 2 of 3 volunteers when reflectance was read 1 week after the last injection (Dorr et al., Life Sci, 1996, PMID 8637402). The receptor fires within minutes of each dose. The pigment arrives on the melanocyte's schedule.
That schedule is set by how melanin is built and moved. Melanocytes assemble eumelanin inside melanosomes, hand the packages to the keratinocytes around them, and those keratinocytes take about 4 weeks to reach the skin surface. With melanotan 1, the linear sibling that shares MT2's Nle4-D-Phe7 core, forearm eumelanin rose 98% and forehead eumelanin 49% one week after a 10-dose course ended, and the eumelanin-to-pheomelanin ratio climbed from 51:1 to 86:1 (Dorr et al., Photochem Photobiol, 2000, PMID 11045725). The darkroom keeps working after the chemistry has drained away.
Onset Timeline: From the First Dark Freckle to a Full Tan
This timeline assumes a standard daily loading phase, skin type II to IV, and 2 to 3 short UV sessions a week.
| When | What you see | What is happening |
|---|---|---|
| Days 1 to 3 | Flushing and mild nausea in the hour after each shot; nothing in the mirror | MC1R signaling has started, tyrosinase output is rising, no new pigment has reached the surface |
| Days 3 to 7 | Freckles, existing moles and old scars darken; the face goes first | Melanocyte-dense spots respond first, the same face-and-upper-body pattern seen in the pilot trial |
| Week 2 | Tan lines after a UV session hold instead of fading overnight | The first wave of eumelanin-loaded keratinocytes is surfacing |
| Week 3 | A tan other people comment on; skin types III and IV near their goal | Pigment production and keratinocyte turnover are both running |
| Weeks 4 to 6 | Peak depth; skin types I and II reach a tan sun alone never gave them | Eumelanin content peaks 1 to 3 weeks after the last loading dose |
The lag is the part most people misread. In the randomized trial of melanotan 1, 28 men received 10 injections over 12 days while wearing high-potency sunscreen, no placebo subject darkened, and peak darkening appeared 1 to 3 weeks after the injections ended (Levine et al., JAMA, 1991, PMID 1658407). The skin you see on the last day of loading is 1 to 3 weeks behind the drug.
The pharmacokinetic trial of the same molecule found the same shape: tanning of the forehead, arms and neck peaked 1 week after dosing and was still present 3 weeks after the ten-dose course (Ugwu et al., Biopharm Drug Dispos, 1997, PMID 9113347). MT2 users report the same curve, usually a week or so faster at the visible stage because most pair it with UV.
MT2 Half-Life: How Long Melanotan 2 Stays in Your System
No PubMed-indexed human study reports a half-life for melanotan 2. The "33 hours" that circulates on vendor pages has no published source behind it. What exists is a pharmacokinetic trial of melanotan 1 and a side-effect clock from the MT2 pilot study, and together they put MT2's plasma life in hours rather than days.
In three volunteers, subcutaneous melanotan 1 was fully bioavailable, its beta-phase plasma half-life ran 0.8 to 1.7 hours, and oral dosing produced no detectable drug at all (PMID 9113347). MT2's lactam bridge shields it from the peptidases that trim the linear molecule, so its half-life is plausibly longer than melanotan 1's. The pilot study caps the estimate: the stretching, yawning and spontaneous erections appeared intermittently for 1 to 5 hours after dosing and then stopped (PMID 8637402). A drug with a 33-hour half-life would not switch off its most sensitive effect by dinner.
The working estimate on this site is a plasma half-life of a few hours, with the drug largely gone within 24 hours of a dose. That is why loading is daily and why a missed day costs little. Model your own schedule in the peptide half-life tracker. PT-141, the melanocortin agonist developed from MT2 for sexual function, runs on the same hours-long window; its clock is in how long PT-141 lasts.
| What clears | How fast | What persists | How long |
|---|---|---|---|
| MT2 in plasma | Hours | Raised tyrosinase activity in melanocytes | 1 to 3 days per dose |
| Nausea and flushing | 1 to 4 hours | New eumelanin inside melanocytes | Weeks |
| Yawning, erections, appetite dip | 1 to 5 hours | Pigmented keratinocytes in the epidermis | 4 to 8 weeks per turnover cycle |
So "how long does MT2 last" has two answers. The molecule: about a day. The tan: a month or more.
How Long the Tan Lasts After You Stop
The tan outlives the drug by a month or more. Both Arizona trials stopped cold with no maintenance dose, and pigment kept rising afterward: peak darkening 1 to 3 weeks after the last injection (PMID 1658407), tanning still present 3 weeks after the course (PMID 9113347).
After the peak, the fade follows keratinocyte turnover. Each 4-week cycle sheds the top layer of pigmented cells, and nothing replaces the extra eumelanin once MC1R stimulation has stopped. User reports, with no trial behind them, put the noticeable fade at 4 to 8 weeks without UV or maintenance and 2 to 3 months with occasional sun. Fair skin fades back to baseline fastest because it started lowest.
The lag also explains the classic overshoot. People keep loading through week 4 because the mirror is behind, then watch the skin darken for another 2 weeks after they stop. Stop loading at the shade one step lighter than you want, and let the lag finish the job.
What Changes the Timeline: Skin Type, UV, Dose and Frequency
| Factor | Effect on the clock | Evidence |
|---|---|---|
| Skin type I or II | Slower visible change in week 1 because baseline melanin is low; reaches a real tan by weeks 4 to 6 | Both skin type I/II and III/IV groups darkened significantly in the randomized trial (PMID 1658407) |
| MC1R variants, red hair, freckling | No measurable reduction in response | Neither MC1R variants nor fair skin reduced the afamelanotide-induced pigmentation increase in two volunteer trials (Minder et al., Clin Pharmacokinet, 2017, PMID 28063031) |
| UV exposure | Sets depth and brings the visible stage forward by about a week; trial subjects tanned under sunscreen, so UV is an amplifier rather than a requirement | Darkening under high-potency sunscreen (PMID 1658407) |
| Dose | A higher dose does not speed the melanocyte; 5 low doses were enough for measurable pigment, and side effects scale with dose | Pilot study (PMID 8637402) |
| Frequency | Alternating-day dosing tanned 2 of 3 subjects; daily loading is faster but not required | Pilot study (PMID 8637402) |
| Product quality | Degraded or underdosed peptide is the most common cause of a flat week 3 | Storage rules in how to store peptides |
Two of these deserve a sentence each. UV first: week-1 skin has baseline melanin and nothing more, because eumelanin in the melanotan 1 biopsies rose only after the course had ended (PMID 11045725). A sunbed binge in week 1 burns exactly as it would without the peptide. Product second: a vial reconstituted with the wrong water, left on a counter, or run through repeated freeze-thaw cycles delivers an unknown fraction of its label. The technique is in how to reconstitute a peptide.
Side Effects on the Same Clock: Nausea, Flushing, Erections and Moles
Most MT2 side effects live inside the drug's hours-long window and fade with repeated dosing. One does not, and it is the one that matters.
| Effect | When it appears | How often, in trials |
|---|---|---|
| Nausea | 30 minutes to 4 hours after injection | Mild at most dose levels in the pilot (PMID 8637402); severe after 4 of 19 injections at 0.025 mg/kg (Wessells et al., Urology, 2000, PMID 11018622) |
| Facial flushing | Within the first hour | Occasional, alongside gastrointestinal upset, with melanotan 1 (PMID 9113347) |
| Stretching, yawning, spontaneous erections | 1 to 5 hours after dosing | Erections in 8 of 10 men with psychogenic erectile dysfunction at 0.025 mg/kg; rigidity above 80% lasted a mean 38 minutes versus 3 minutes on placebo (Wessells et al., J Urol, 1998, PMID 9679884) |
| Somnolence and fatigue | Same day | WHO grade II in 1 of 2 subjects at 0.03 mg/kg (PMID 8637402) |
| Darkening of existing moles | Days 3 to 7 | Expected; uniform darkening of a stable mole is the normal first sign |
| New or changing moles | Weeks to months | Case reports of melanocytic changes and new dysplastic nevi; 4 published melanomas arising from existing moles during or shortly after melanotan use (Habbema et al., Int J Dermatol, 2017, PMID 28266027) |
The erection data are the clearest dose marker you have. In men with organic erectile dysfunction, 0.025 mg/kg produced erections after 12 of 19 injections versus 1 of 21 on placebo, raised sexual desire, and caused severe nausea after 4 of 19 injections, roughly 1 in 5 (PMID 11018622). That dose is 2 mg for an 80 kg adult, well above typical community doses. Unwanted erections plus strong nausea on a tanning dose means the vial, or the dose, is stronger than you think. The sexual-function side of the molecule is covered under PT-141 for men.
Moles are the exception to "it fades by the weekend". A 40-year-old man with a history of melanoma and multiple dysplastic nevi self-injected a synthetic alpha-MSH analog and grew crops of new, often atypical, pigmented nevi while his existing moles darkened and started growing; the nevi regressed after he quit (Cardones et al., Arch Dermatol, 2009, PMID 19380666). Photograph every mole before dose one, re-shoot monthly, and treat any new mole, any mole that grows, or any irregular border as a stop signal and a dermatology appointment. A personal or family history of melanoma is a reason to skip the compound entirely.
When No Results Means Something Is Wrong
True non-response is rare in the published data: 2 of 3 MT2 subjects pigmented in the pilot (PMID 8637402), every melanotan 1 subject darkened in the randomized trial (PMID 1658407), and MC1R variants did not blunt afamelanotide (PMID 28063031). When the mirror shows nothing, the cause is almost always one of these four.
1. Judging during the lag. Day 7 skin reflects day 1 pigment production. Freckles and moles are the early gauge; the tan itself is 1 to 3 weeks behind the last dose. Nausea is no gauge at all: it is melanocortin activity in the gut and brain, and it fades by dose 3 to 5 while the tan is still weeks away.
2. Degraded product. Peptide in bacteriostatic water held at room temperature, exposed to light, or frozen and thawed several times loses potency with no visible change in the vial. Storage limits are in how to store peptides.
3. Zero UV on fair skin. The randomized trial detected darkening under sunscreen with a chromaticity meter (PMID 1658407). Your eye is a worse instrument. Two short UV sessions a week usually make a week-2 tan visible that was already there.
4. An underdosed or mislabeled vial. Research-compound MT2 has no regulator checking the label. A vial that produces neither flushing nor nausea nor mole darkening in the first week most likely contains less peptide than claimed. Check the unit math in the melanotan 2 dosage calculator before blaming the product, then change the product rather than the dose.
| Checkpoint | What to expect | If it is absent |
|---|---|---|
| Day 7 | Freckles and moles darker, flushing after shots | Check storage and reconstitution, continue |
| Day 14 | Tan lines that hold after UV | Add 2 short UV sessions a week; do not raise the dose |
| Day 21 | A tan others notice | Stop. The product is the likely fault, and escalation is not the fix |
Escalation is where the pilot study turned: a step from 0.025 to 0.03 mg/kg, a 20% increase, produced grade II somnolence and fatigue in 1 of 2 subjects (PMID 8637402). Raising the dose to chase a tan that is lagging buys nausea now and the same tan later. If a protocol already includes a prescription drug, run the pairing through the peptide interaction checker before adding anything.
Frequently Asked Questions
How long does MT2 take to work?
Measurable darkening after about 5 doses, a tan other people notice in 2 to 3 weeks with modest UV, and a peak 1 to 3 weeks after the last loading dose. In the pilot study, 5 alternating-day doses pigmented the face and upper body in 2 of 3 volunteers (PMID 8637402). The mechanism is in the melanotan 2 profile.
What is the half-life of melanotan 2?
No human study has published one. The closest tested analog, melanotan 1, has a subcutaneous beta-phase half-life of 0.8 to 1.7 hours (PMID 9113347), and MT2 side effects stop within 1 to 5 hours of a dose (PMID 8637402). A working estimate is a few hours. Model it in the peptide half-life tracker.
How long does MT2 stay in your system?
The molecule is largely gone within 24 hours of a dose; nausea, flushing and spontaneous erections end inside 1 to 5 hours (PMID 8637402). The tan it triggered lasts weeks after the drug is gone. Its relative PT-141 runs on the same hours-long window, detailed in how long PT-141 lasts.
How long does the melanotan 2 tan last after you stop?
The tan keeps deepening for 1 to 3 weeks after the last dose and was still measurable 3 weeks after a 10-dose course in the melanotan 1 trials (PMID 1658407, PMID 9113347). User reports put the noticeable fade at 4 to 8 weeks without UV and 2 to 3 months with occasional sun. The unit math for any further dosing is in the melanotan 2 dosage calculator.
Does melanotan 2 work without sun?
Yes, measurably. In the randomized trial, every subject wore high-potency sunscreen and the treated group still darkened significantly while placebo did not (PMID 1658407). Without UV the visible stage arrives about a week later and the final depth is lighter. If a sunless run shows nothing by week 3, check the vial against how to store peptides.
Why is melanotan 2 not working after 2 weeks?
Usually the lag: skin trails the drug by 1 to 3 weeks, so day 14 shows day 1 output. After that, degraded or underdosed peptide is the common cause, since true non-response is rare and MC1R variants did not blunt afamelanotide (PMID 28063031). Check reconstitution first in how to reconstitute a peptide, then change the product rather than the dose.
Is it normal for moles to darken on MT2?
Uniform darkening of existing moles and freckles in days 3 to 7 is the expected first sign. New moles, moles that grow, or irregular borders are different: 4 published melanomas arose from existing moles during or shortly after melanotan use (PMID 28266027). Photograph moles before dose one. The risk profile is in the melanotan 2 profile.
The Bottom Line
Melanotan 2 darkens freckles and moles in days 3 to 7, produces a tan other people notice in 2 to 3 weeks with modest UV, and peaks 1 to 3 weeks after the last loading dose. No human half-life has been published; the drug behaves as if it clears in hours, and the tan it leaves behind lasts a month or more.
The principle: the molecule is the developer and the pigment is the print. Judge MT2 by freckles and tan lines on a 3-week clock, stop loading one step early, and treat a flat week 3 as a product problem rather than a dose problem.
Melanotan 2 is not FDA-approved for any use and is sold as a research compound; the trial data behind this page come from fewer than 60 volunteers, and the mole and melanoma reports are the reason to photograph your skin before dose one. Run your units through the melanotan 2 dosage calculator and find the rest of the melanocortin cluster at PeptidesExplorer. Educational content, not medical advice.
Related Articles
How Long Does KPV Take to Work? Timeline
How long does KPV take to work: gut symptoms in 1 to 2 weeks, skin in 2 to 4, systemic inflammation in 2 to 6. Half-life, onset by route, and when to stop.
Cagrilintide Half-Life: How Long It Stays in Your System
Cagrilintide half-life is 7 to 8 days (phase 1b data). Steady state in 4 to 5 weeks, 5-week washout, why it matches semaglutide, missed-dose and nausea math.
Melanotan 2 Dosage Chart by Skin Type
Melanotan 2 dosage: start 0.25 mg/day loading, then 0.5 mg 1-2x weekly. Full chart by Fitzpatrick skin type, nausea fixes, and nasal vs injection compared.
MOTS-c Half-Life: How Long It Stays in Your System
MOTS-c half-life: no human PK study exists. Exercise-raised plasma MOTS-c clears within 4 hours, yet gene effects last days. Washout, detectability, drug tests.